Scroll To Top

Prevention

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.

With a new case in Sweden, what is the new mpox outbreak and should you be concerned?

Things to know about the resurgence of mpox.

Paris Olympics will give out 300,000 condoms to athletes, continuing long-held tradition

300,000 condoms will be available in the Paris Olympic Village, returning to tradition after the IOC issued an intimacy ban and social distancing orders for the 2021 Tokyo Olympics.

Biden officials urged syphilis, hepatitis & HIV tests on National HIV Testing Day

It’s called the "syndemic approach" and sexually active people should know about it, health officials say.

Yes, HIV-positive people can safely breastfeed

On a recent episode of +Talk, two experts relay the real facts about breastfeeding when living with HIV.

Court rules to keep PrEP coverage under Obamacare

A lower court had ruled that requiring PrEP coverage was akin to supporting homosexuality and, therefore, a violation of religious rights. However, advocates are concerned about further legal challenges that may appear.

In honor of Juneteenth 2024, meet The Normal Anomaly

This Black, queer-led organization is addressing the intersectional challenges their communities face, including HIV.

Everything you need to know about the new fungal infection impacting the LGBTQ+ community

A new case of sexually transmissible tinea has been reported in New York that can take months to clear up.

The science behind U=U has been liberating people with HIV for years

A look back on how research and radical activism have worked together to harness the power of U=U.

The government failed on mpox. Ritchie Torres's new bill addresses that

A new report highlights significant flaws in the federal handling of the mpox outbreak, emphasizing the need for a more unified response system to tackle future public health emergencies.

Why are mpox cases in the U.S. on the rise again?

Experts point to a lag in vaccination rates in addition to other looming new threats.

Injectable HIV treatment, prevention: Everything you need to know

So much has changed when it comes to injectables — get some clarity here.

Is this the future of PrEP?

A new study found combining treatments could lead to an astounding reduction of HIV transmissions.

Queer men aren't the only ones affected by recent syphilis spike

Maternal syphilis rates in the U.S. have tripled in recent years, CDC report shows, raising infection risk for infants.

PrEP without a prescription now a reality in California

Governor Newsom signed a bill on Tuesday greatly increasing access to the preventative HIV medication.

Government steps in to stop ongoing syphilis spike

As cases continue to surge in the U.S., recent federal efforts aim to tackle the alarming trend.

The latest on an HIV vaccine

Many scientists are undeterred in the effort to prevent HIV without a lifetime of medication.

The Most Amazing HIV Allies & Advocates of 2023

We celebrate some of the HIV community's greatest heroes who are smashing stigma and working to eliminate the epidemic once and for all.

PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program

Although PEPFAR has saved an estimated 25 million lives over the past 20 years (and was created by a Republican administration), extreme conservatives are attempting to shut it down.

As Syphilis Cases Rise, Clinics Struggle to Get Proper Antibiotic

The preferred treatment for syphilis is in short supply, and experts are urging the White House to intervene.